Patrick McEnany

Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) lost nearly half of its value Wednesday morning after the company disclosed it received a "Refusal to File" letter from the U.S. Food and Drug Administration. The "Refusal to File" letter was sent to Catalyst...